Tara Hiltke, Ph.D.
Office Deputy Director
Dr. Hiltke assists in developing and implementing plans and goals for the Office of Cancer Clinical Proteomics Research. She also provides leadership and oversight to the Monoclonal Antibody Characterization program. Previously, Dr. Hiltke served as a senior scientist/project manager in assay development at both Wellstat Diagnostics and BioVeris Corporation, where she developed clinical assays for diagnostic markers.
Education
- Ph.D., Molecular Biology, University of Buffalo, Buffalo, NY
- B.S. Biology, Nazareth University, Rochester, NY